Evidence map›Paper›PMID 40034157›Full record

ArticleFrontiers in plant science2025

Engineering and application of multiepitope recombinant proteins to enhance resistance to

Xiaxia Man, Huang You, Zhiqiang Cheng, Junhao Li, Dunchao Yao, Haofeng Wang, Zhihong Diao, Xiaosong Yu, Wei Wu, Cheng Zhou and 4 more

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Secreted proteins fromFrontiers in plant science · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaxia Man *College of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Huang You *College of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Zhiqiang Cheng *College of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Junhao LiCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Dunchao YaoCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Haofeng WangCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Zhihong DiaoCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Xiaosong YuCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Wei WuChengdu Lusyno Biotechnology Co., Ltd, Chengdu, Sichuan, China.
Cheng ZhouChengdu Lusyno Biotechnology Co., Ltd, Chengdu, Sichuan, China.
Yan HuangCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.
Jinbo ShenState Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, Hangzhou, Zhejiang, China.
Xiaohong ZhuangCentre for Cell and Developmental Biology, State Key Laboratory of Agrobiotechnology, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Yi CaiCollege of Life Sciences, Sichuan Agricultural University, Yaan, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant elicitors have emerged as key agents in effectively invoking immune responses across various plant species, gaining attention for their role in sustainable agricultural protection strategies. However, the economic utility of peptide elicitors such as flg22, flgII-28, and systemin is limited when considering broader agricultural applications. This study introduces a novel recombinant protein, SlRP5, which integrates five active epitopes-flg22, csp22, flgII-28, SIPIP1, and systemin-to activate immune responses and significantly enhance resistance to

Indexed as

Botrytis cinerea resistanceplant elicitorrecombinant proteinTMVtomato immunity

Identifiers

PMID40034157
PMCPMC11873852

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.